Norel AD
- Product NDC
- 52747-475
- 11-digit product format
- 527470475
- Labeler code
- 52747
- Product ID
- 52747-475_41619e00-e834-2cf6-e063-6394a90a259d
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- acetaminophen, chlorpheniramine maleate, and phenylephrine HCl
- Dosage form
- TABLET, MULTILAYER
- Route
- ORAL
- Labeler
- U.S. PHARMACEUTICAL CORPORATION
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2012-04-27
- Substance
- ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE
- Active strength
- 325; 4; 10 mg/1; mg/1; mg/1
- Pharmacologic classes
- Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Norel AD
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ACETAMINOPHEN | 325 mg/1 |
| CHLORPHENIRAMINE MALEATE | 4 mg/1 |
| PHENYLEPHRINE HYDROCHLORIDE | 10 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 362O9ITL9D, V1Q0O9OJ9Z, 04JA59TNSJ |
| Rxcui | 1193293 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 52747-475-70 | Norel AD | 20 in 1 BOTTLE | TABLET, MULTILAYER | 20 | | 14 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ACETAMINOPHEN | ACTIVE INGREDIENT | 362O9ITL9D | NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] | 5 | |
| CHLORPHENIRAMINE MALEATE | ACTIVE INGREDIENT | V1Q0O9OJ9Z | NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] | 5 | |
| PHENYLEPHRINE HYDROCHLORIDE | ACTIVE INGREDIENT | 04JA59TNSJ | NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] | 5 | |
| ACETAMINOPHEN | ACTIVE MOIETY | 362O9ITL9D | NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] | 5 | |
| CHLORPHENIRAMINE | ACTIVE MOIETY | 3U6IO1965U | NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] | 5 | |
| PHENYLEPHRINE | ACTIVE MOIETY | 1WS297W6MV | NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] | 5 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] | 5 | |
| COLLOIDAL SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] | 5 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] | 5 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] | 5 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] | 5 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] | 5 | |
| POVIDONE K30 | INACTIVE INGREDIENT | U725QWY32X | NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] | 5 | |
| STARCH, PREGELATINIZED CORN | INACTIVE INGREDIENT | O8232NY3SJ | NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] | 5 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] | 5 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 52747-475 | NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [U.S. PHARMACEUTICAL CORPORATION] | 13 | Current NDC, Legacy NDC, 1 package rows | 20241017_53d9ed3c-212d-4b12-ac35-8bd49382b49d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 52747-475-70 | 52747047570 | 20 TABLET, MULTILAYER in 1 BOTTLE (52747-475-70) | 2012-04-27 | 0000-00-00 | No | No | Current |